Ind-Swift Laboratories Ltd. is a global manufacturer of APIs, Intermediates, and formulations. Headquartered in Chandigarh, India, the company has 6+ manufacturing sites in Punjab and Jammu. They cater to the API needs of regulated markets including USFDA, EDQM, PMDA, ANVISA, EU-GMP, KFDA, NMO, ANSM, Cofepris, TGA, WHO, and ROW. Ind-Swift Laboratories specializes in manufacturing APIs for cardiovascular health, antihistamine, antidiabetic, antipsychotic, antimigraine, Parkinson's disease, antineoplastic, ADHD symptoms, analgesics, alcohol abstinence, and bone resorption inhibitor. They also have a strong presence in the macrolide antibiotic segment. The company's manufacturing facilities have received approvals and certifications from global regulatory agencies. They have a dedicated research and development center focused on developing and optimizing process technologies for APIs. Ind-Swift Laboratories aims to become an industrial leader in the world and provides high-quality products and services to their customers.
Legal Address
SCO 850, Shivalik Enclave,, NAC, Manimajra,
Chandigarh; Punjab;
Postal Code: 160101
Contact Details: Purchase the Ind-Swift Laboratories Ltd. report to view the information.
Website: http://www.indswiftlabs.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS service
To view more information, Request a demonstration of the EMIS service